Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity

Details for Australian Patent Application No. 2006214378 (hide)

Owner Schering Corporation Pharmacopeia Drug Discovery, Inc.

Inventors Dong, Guizhen; Yang, Changmeng; Anilkumar, Gopinadhan N.; Kozlowski, Joseph A.; Zawacki, Lisa Guise; Rosenblum, Stuart B.; Carroll, Carolyn Dilanni; Jenh, Chung-Her; McGuinness, Brian F.; Shih, Neng-Yang; Zavodny, Paul J.; Shao, Yuefei; Hobbs, Douglas W.; Kim, Seong Heon

Agent Griffith Hack

Pub. Number AU-A-2006214378

PCT Pub. Number WO2006/088919

Priority 60/653,337 16.02.05 US

Filing date 14 February 2006

Wipo publication date 24 August 2006

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

C07D 211/58 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/088919 Priority application(s): WO2006/088919

17 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006214380-Pyrazinyl substituted piperazinepiperidines with CXCR3 antagonist activity

2006214371-Mineral technologies (MT) for acute hemostasis and for the treatment of acute wounds and chronic ulcers